14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AQXP
Delisted

Aquinox Pharmaceuticals Stock Price (Quote)

$12.53
+0.0500 (+0.401%)
At Close: Apr 24, 2020

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 24th Apr 2020 AQXP stock ended at $12.53. This is 0.401% more than the trading day before Thursday, 23rd Apr 2020. During the day the stock fluctuated 6.46% from a day low at $12.38 to a day high of $13.18.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Aquinox Pharmaceuticals prices

Date Open High Low Close Volume
Feb 15, 2018 $16.39 $16.70 $16.02 $16.31 184 803
Feb 14, 2018 $15.98 $16.90 $15.46 $16.25 205 678
Feb 13, 2018 $14.96 $16.60 $14.48 $16.00 268 212
Feb 12, 2018 $15.24 $15.26 $14.17 $14.98 130 622
Feb 09, 2018 $13.76 $15.92 $13.76 $15.31 554 055
Feb 08, 2018 $13.63 $13.74 $13.07 $13.40 185 511
Feb 07, 2018 $13.40 $13.89 $13.04 $13.62 91 694
Feb 06, 2018 $12.85 $13.49 $12.14 $13.39 60 489
Feb 05, 2018 $13.35 $13.69 $12.90 $13.01 57 602
Feb 02, 2018 $12.97 $13.40 $12.81 $13.38 250 421
Feb 01, 2018 $12.90 $13.23 $12.75 $13.03 64 292
Jan 31, 2018 $13.00 $13.32 $12.79 $12.93 122 138
Jan 30, 2018 $13.15 $13.31 $12.48 $13.00 132 247
Jan 29, 2018 $12.39 $13.26 $12.39 $13.11 174 883
Jan 26, 2018 $12.21 $12.50 $12.09 $12.38 79 832
Jan 25, 2018 $12.20 $12.57 $11.85 $12.20 111 672
Jan 24, 2018 $12.36 $12.85 $12.16 $12.20 126 579
Jan 23, 2018 $12.39 $12.57 $12.03 $12.35 69 082
Jan 22, 2018 $11.99 $12.44 $11.91 $12.24 113 123
Jan 19, 2018 $11.87 $11.90 $11.52 $11.75 120 268
Jan 18, 2018 $10.82 $11.93 $10.82 $11.78 103 910
Jan 17, 2018 $11.40 $11.72 $11.33 $11.56 58 501
Jan 16, 2018 $11.66 $11.69 $11.00 $11.47 74 039
Jan 15, 2018 $11.51 $11.51 $11.51 $11.51 0
Jan 12, 2018 $11.32 $11.78 $11.32 $11.51 29 122
Click to get the best stock tips daily for free!

About Aquinox Pharmaceuticals

Aquinox Pharmaceuticals Aquinox Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The company primarily focuses on anti-inflammatory product candidates targeting SH2-containing inositol-5’-phosphatase 1 (SHIP1) enzyme, a key regulator of a cellular signaling pathway in immune cells. Its lead product candidate is AQX-1125, a small molecule acti... AQXP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT